-
Why This Analyst Set A $3 Price Target On SINTX Shares
Thursday, September 12, 2019 - 9:46am | 400Read More...The FDA-registered silicon nitride medical device manufacturing facility company SINTX Technologies Inc (NASDAQ: SINT) boasts five near-term catalysts that should help the stock double in value, according to Ascendiant Capital Markets. Sintx said in a Wednesday press release that it has...
-
OpenTable Write Down Wasn't Too Material To Priceline's Overall Business
Tuesday, November 8, 2016 - 10:16am | 364Read More...Ascendiant Capital Markets maintains its Buy rating on Priceline Group Inc (NASDAQ: PCLN) as continued strong hotel growth and international momentum led to better-than-expected results for the third quarter. Also, the brokerage said the $941 million OpenTable write -down is not material, as it...
-
MGT Capital Initiated Buy At Ascendiant, Positive On Co's Cyber Security Focus
Monday, August 15, 2016 - 8:46am | 285Read More...MGT Capital Investments Inc. (NYSE: MGT) announced that it has inked an agreement with D-Vasive Inc to acquire certain technology and assets. The deal marks MGT Capital’s move into cyber security and could be a “major catalyst for the stock,” Ascendiant Capital Markets’...
-
Ascendiant Thinks Priceline's 10% Selloff Is Unwarranted
Thursday, May 5, 2016 - 10:02am | 326Read More...Ascendiant Capital’s Edward Woo believes the 10 percent decline in the share price of Priceline Group Inc (NASDAQ: PCLN) followings its 1Q results was unwarranted, and the share price is likely to recover as the company continued to outperform. The analyst maintains a Buy rating on Priceline...
-
Ascendiant's Woo Says TripAdvisor Worth $100 On Strong Industry, Sees Marriott As 'Big Plus'
Monday, July 20, 2015 - 9:54am | 236Read More...In a report published Monday, Ascendiant Capital Markets analyst Edward Woo maintained a Buy rating on TripAdvisor Inc (NASDAQ: TRIP), while raising the price target from $92 to $100, saying that "growth, scale, and strong travel industry should drive valuation" in the longer term. TripAdvisor is...
-
Ascendiant's Acree Upgrades Intel, Says PC Weakness 'Factored In'
Thursday, July 16, 2015 - 1:07pm | 283Read More...Intel Corporation (NASDAQ: INTC) reported stronger-than-expected second quarter results after Wednesday's market close. In a report, Ascendiant Capital Markets analysts Cody G. Acree and David N. Williams upgraded shares of the company to hold as PC weakness looks already factored in...
-
Ascendiant Capital Bullish On Tesla Post-Q1, But Notes Near-Term Challenges
Thursday, May 7, 2015 - 3:27pm | 428Read More...In a report published Thursday, Ascendiant Capital Markets analyst Theodore O'Neill commented on Tesla Motors Inc (NASDAQ: TSLA)'s first quarter results, noting the company reported both a top and bottom line beat to consensus estimates, but faces several upcoming challenges. According to O'Neill,...
-
Ascendiant Capital Initiates Energous At Buy
Monday, May 4, 2015 - 8:43am | 229Read More...In a report published Monday, analysts at Ascendiant Capital Markets initiated coverage of Energous Corp (NASDAQ: WATT) with a Buy rating and a price target of $13. Energous is an "early stage, pre-revenue technology licensing company developing a potentially disruptive approach to wireless...
-
Analyst: PC Weakness Too Much For Advanced Micro Devices
Friday, April 17, 2015 - 8:45am | 274Read More...In a report published Friday, Ascendiant Capital Markets analyst Cody Acree downgraded shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) to Hold from Buy with no assigned price target (previous price target was $4.50) following its first quarter results. "Following Intel Corporation's negative...
-
Ascendiant Capital Analyst Says Model X Only Risky Item In Tesla Earnings
Wednesday, February 11, 2015 - 12:55pm | 210Read More...Speaking to Benzinga, Ascendiant Capital analyst Theodore O'Neill said that the real risk in Tesla Motors Inc (NASDAQ: TSLA) is further delay deliveries of the Model X. Barring that, he says “the stock should do OK.” Specifically, the Ascendiant Capital is looking for $1.1...
-
Advanced Micro Devices Analyst Roundup Following Q4 Results
Thursday, January 22, 2015 - 7:45am | 628Read More...Advanced Micro Devices, Inc. (NASDAQ: AMD) reported Q4 results inline with expectations Tuesday and the stock surged 9.38 percent Wednesday to $2.45. Analysts commented on the stock following the earnings release. Below are highlights along with current ratings and price targets. Ascendiant...
-
Ascendiant Capital Markets Analyst Theodore O'Neill Says Low Oil Prices Driving Down Tesla Stock
Wednesday, December 3, 2014 - 4:52pm | 102Read More...Speaking to Benzinga, Ascendiant Capital Markets Senior Research Analyst Theodore O’Neill said that cheap gas prices are drawing consumer attention away from electric vehicles like those from Tesla Motors Inc (NASDAQ: TSLA). “[The] stock is trading down as oil prices fall, which...
-
UPDATE: Ascendiant Capital Markets Initiates Coverage On Aldeyra Therapeutics On Intriguing Investment Story
Wednesday, December 3, 2014 - 8:44am | 131Read More...In a report published Wednesday, Ascendiant Capital Markets analyst Keay Nakae initiated coverage on Aldeyra Therapeutics (NASDAQ: ALDX) with a Buy rating and $16.00 price target. In the report, Ascendiant Capital Markets noted, “We believe that Aldeyra Therapeutics is an intriguing speculative...
-
UPDATE: Ascendiant Capital Markets Reiterates On Repros Therapeutics Following Positive Topline Results
Friday, August 29, 2014 - 7:53am | 120Read More...In a report published Friday, Ascendiant Capital Markets analyst Keay Nakae reiterated a Buy rating on Repros Therapeutics (NASDAQ: RPRX), and raised the price target from $23.00 to $25.00. In the report, Ascendiant Capital Markets noted, “We believe that the positive result from the ZA-305 study...
-
UPDATE: Ascendiant Capital Markets Upgrades Pozen Following Q2 Results
Friday, August 8, 2014 - 8:16am | 133Read More...In a report published Friday, Ascendiant Capital Markets analyst Keay Nakae upgraded the rating on Pozen (NASDAQ: POZN) from Hold to Buy, and named a $10.00 price target. In the report, Ascendiant Capital Markets noted, “Pozen has reported Q2 results. Revenue was $7.4 MM compared to consensus of $7...
